Latigo Biotherapeutics, Inc.
Ownership
Ownership Structure
Who owns Latigo Biotherapeutics, Inc. (LTGO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 18.7% of the shares are freely tradable; institutional investors hold 73.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Sanofi | 1.01 | 672,778 | +0.0 | 09/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Contrafund | 1.31 | 868,072 | -7.7 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 0.95 | 629,123 | +1,037.2 | 09/30/2026 |
| Fidelity Select Biotechnology | 0.72 | 480,316 | +0.0 | 08/31/2026 |
| abrdn Healthcare Investors | 0.38 | 253,614 | +0.0 | 09/30/2026 |
| Fidelity Select Health Care | 0.32 | 212,500 | +0.0 | 08/31/2026 |
| abrdn Healthcare Opportunities | 0.32 | 209,941 | +7.2 | 09/30/2026 |
| T. Rowe Price New Horizons | 0.32 | 209,236 | -1.0 | 09/30/2026 |
| abrdn Life Sciences Investors | 0.29 | 193,776 | +55.0 | 09/30/2026 |
| Fidelity Advisor Biotechnology I | 0.29 | 191,400 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| 5AM Ventures VI, L.P. | 10% Owner | 7,325,962 | 94,504,910 $ | Aug 10, 2026 | indirect |
| Sanofi | 10% Owner | 672,788 | 8,678,965 $ | Aug 10, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | 5AM Ventures VI, L.P. | 10% Owner | Other | 2,350,419 | – | – |
| Aug 10, 2026 | 5AM Ventures VI, L.P. | 10% Owner | Other | 4,975,543 | – | – |
| Aug 10, 2026 | Sanofi | 10% Owner | Other | 177,978 | – | – |
| Aug 10, 2026 | Sanofi | 10% Owner | Other | 494,800 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.